• WuXi Biologics, ABL Bio Enter Development Deal contractpharma
    November 30, 2018
    WuXi Biologics and ABL Bio Corporation have entered into an exclusive development and clinical manufacturing partnership for up to 8 antibody therapeutics including ABL Bio’s biologics pipelines and collaboration programs between...
  • Paragon Named to Deloitte's Technology Fast 500 contractpharma
    November 27, 2018
    Paragon Bioservices was named to Deloitte's Technology Fast 500™ for 2018, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies
  • ORIC Pharma Appoints CBO firstwordpharma
    November 27, 2018
    Matt Panuwat has been appointed chief business officer at ORIC Pharmaceuticals, a clinical-stage oncology company focused developing novel therapies against treatment-resistant cancers.
  • EU rules may be stifling Britain's biotech industry pharmafile
    November 20, 2018
    EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph.
  • Israel to build first biotechnology plant producing new AIDS drug biospectrumasia
    October 25, 2018
    The new drug eliminates the HIV virus-infected cells, as opposed to previous drugs which focused on eliminating the virus itself, and therefore faced the risk of viruses changing and developing resistance.
  • Scottish government invests £11m into Glasgow biotechnology centre pharmafile
    September 20, 2018
    The Scottish government is investing £11 million into the Glasgow-based Industrial Biotechnology Innovation Centre (IBioIC)...
  • Cell Research Corporation announces new senior advisors biospectrumasia
    August 29, 2018
    CellResearch identified the broad applicability of cord lining mesenchymal and epithelial stem cells as potential treatments for an extensive number of indications including Haemophilia A, myocardial infarction and Parkinson’s disease.
  • Prothena announces new COO biospectrumasia
    June 27, 2018
    Nguyen currently serves on the board of directors of Sierra Oncology, Inc., a public clinical-stage oncology company and Rain Therapeutics Inc., a private clinical-stage oncology company.
  • Cuba and China expand cooperation in the field of biotechnology biospectrumasia
    May 21, 2018
    This is the second agreement of its kind signed this week between the two nations. It involves BioCubaFarma business group, the Chinese State Development and Investment Corporation (SDIC) and Sino-Pharma company.
  • Italy Biotechnology Market Trends, Analysis & Forecast Up To 2025 biospace
    April 10, 2018
    Italy Biotechnology market is expected to witness a strong growth rate in the medium to long term future.
PharmaSources Customer Service